Would have loved a blowout surprise and am somewhat disappointed with the miss which could have been managed, or at least preannounced.
Also, disappointed that there is still no guidance.
No update on progress in Canada, Mexico, Switzerland, Taiwan, et al. The EPS miss was primarily due to revaluation of derivatives and a HUGE increase in R&D to advance the pipeline. The first is a non-issue and the second is actually positive, showing aggressive investment in moving the pipeline forward. Good to know that we will have results from at least 3 trials by this time next year.
All in all, nothing really new, but, I think expectations of faster acceptance and revenue growth are not being met which is keeping SP down, as well as a very conservative or nonexistent PR program. With all the good news and potential, the co. should be meeting with analysts and working to get some recs and upgrades.
If your were a longterm holder none of what you posted would be a concern. Do you think approval in other countries are in their control ? Dtc ads started less then a month ago and people are expecting miracles! Realistic longterm hold means 3-5 years. This is still a baby bio with a pipeline that doesn't exists yet!